Appili Therapeutics Inc. (APLIF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 8.18 Million CAD | 64.4% |
| 2023 | 4.97 Million CAD | 382.15% |
| 2022 | 1.03 Million CAD | 2.75% |
| 2021 | 1 Million CAD | -10.16% |
| 2020 | 1.11 Million CAD | 0.0% |
| 2019 | 1.11 Million CAD | 0.65% |
| 2018 | 1.11 Million CAD | 158.47% |
| 2017 | 430 Thousand CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 5.23 Million CAD | 5.12% |
| 2024 Q2 | 5.41 Million CAD | 3.45% |
| 2024 FY | 8.18 Million CAD | 64.4% |
| 2024 Q4 | 8.18 Million CAD | 2.16% |
| 2024 Q3 | 8.01 Million CAD | 47.98% |
| 2023 Q1 | 5.23 Million CAD | 5.12% |
| 2023 Q3 | 5.44 Million CAD | 0.5% |
| 2023 Q4 | 4.97 Million CAD | -8.5% |
| 2023 Q2 | 5.41 Million CAD | 3.45% |
| 2023 FY | 4.97 Million CAD | 382.15% |
| 2022 Q2 | 3.8 Million CAD | 274.45% |
| 2022 Q1 | 1.01 Million CAD | -1.69% |
| 2022 FY | 1.03 Million CAD | 2.75% |
| 2022 Q4 | 4.97 Million CAD | 65.85% |
| 2022 Q3 | 3 Million CAD | -21.03% |
| 2021 Q2 | 1.01 Million CAD | 0.93% |
| 2021 FY | 1 Million CAD | -10.16% |
| 2021 Q4 | 1.03 Million CAD | -0.59% |
| 2021 Q1 | 1 Million CAD | -0.09% |
| 2021 Q3 | 1.03 Million CAD | 2.5% |
| 2020 FY | 1.11 Million CAD | 0.0% |
| 2020 Q3 | 1.01 Million CAD | 0.43% |
| 2020 Q2 | 1 Million CAD | 0.68% |
| 2020 Q1 | 1 Million CAD | -10.55% |
| 2020 Q4 | 1 Million CAD | -0.66% |
| 2019 Q4 | 1.11 Million CAD | 15.52% |
| 2019 Q3 | 968.3 Thousand CAD | 0.0% |
| 2019 FY | 1.11 Million CAD | 0.65% |
| 2019 Q1 | - CAD | -100.0% |
| 2018 Q4 | 1.11 Million CAD | 0.0% |
| 2018 FY | 1.11 Million CAD | 158.47% |
| 2017 FY | 430 Thousand CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 80.135% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -98.567% |
| SQZ Biotechnologies Company | 27.47 Million USD | 70.205% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 81.129% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 72.504% |
| Mesoblast Limited | 118.7 Million USD | 93.105% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -763.135% |
| Genus plc | 233.1 Million USD | 96.489% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -179.31% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -509.181% |
| Marizyme, Inc. | 18.71 Million USD | 56.272% |
| ContraFect Corporation | 2.88 Million USD | -184.098% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -991.314% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -5941.064% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -465.909% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -251.892% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -44.651% |
| MultiCell Technologies, Inc. | 202.58 USD | -4040208.026% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 85.763% |
| EV Biologics, Inc. | 1.49 Million USD | -447.573% |
| Q BioMed Inc. | 4.1 Million USD | -99.146% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 75.273% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -1199.025% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -566.323% |
| Biomind Labs Inc. | 735.54 Thousand USD | -1012.765% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 95.229% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | 37.025% |
| Skye Bioscience, Inc. | 4.61 Million USD | -77.343% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -821.652% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -5683.615% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -39.409% |
| IMV Inc. | 28.88 Million USD | 71.663% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -31724.161% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -262.421% |
| GB Sciences, Inc. | 1.75 Million USD | -365.232% |
| Alpha Cognition Inc. | 1.22 Million USD | -570.685% |
| HST Global, Inc. | 98.31 Thousand USD | -8224.796% |
| CSL Limited | 12.18 Billion USD | 99.933% |
| Halberd Corporation | 150 Thousand USD | -5356.571% |
| Enzolytics Inc. | 996.33 Thousand USD | -721.494% |
| Resverlogix Corp. | 6.49 Million USD | -26.095% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -1614.106% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -3102.313% |
| argenx SE | 20 Million USD | 59.076% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 82.035% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -202.169% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -79947.491% |
| Genscript Biotech Corporation | 417.73 Million USD | 98.041% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -3979.862% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -241.359% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -3469.637% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 87.9% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -170.467% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -2175.404% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | 59.736% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -5405.978% |
| BioStem Technologies, Inc. | 4.71 Million USD | -73.724% |
| ONE Bio Corp. | 19.71 Million USD | 58.484% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -3171.561% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -3190.791% |
| Agentix Corp. | 50 Thousand USD | -16269.712% |
| LadRx Corporation | 33.6 Thousand USD | -24255.341% |
| Cell Source, Inc. | 9.25 Million USD | 11.555% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -982.361% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -982.361% |
| NovAccess Global Inc. | 2.19 Million USD | -272.059% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -15.723% |
| Itoco Inc. | 228.37 Thousand USD | -3483.923% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -3779.538% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -64.256% |
| Kadimastem Ltd | 891.22 Thousand USD | -818.382% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -1936.799% |
| CytoDyn Inc. | 30.07 Million USD | 72.786% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -1590.094% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -2226.254% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -4.666% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -6581.515% |
| Rebus Holdings, Inc. | 310 Thousand USD | -2540.276% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -72.848% |
| International Stem Cell Corporation | 4.17 Million USD | -95.904% |
| Bioxytran, Inc. | 1.92 Million USD | -325.187% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -13014.024% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -275.297% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | 1.577% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | 4.661% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -426.195% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -2954.051% |
| Neutra Corp. | 54.15 Thousand USD | -15013.48% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -347.26% |
| PureTech Health plc | 25.51 Million USD | 67.918% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -568.574% |
| IXICO plc | 472.02 Thousand USD | -1633.995% |
| IntelGenx Technologies Corp. | 15.5 Million USD | 47.198% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 86.854% |
| CSL Limited | 12.18 Billion USD | 99.933% |
| Cellectis S.A. | 92.77 Million USD | 91.178% |